LEN vs NUS · rev $34.19B vs P/E 4.9, rev $1.73B
LEN (LEN) versus Nu Skin Enterprises Inc (NUS) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Nu Skin Enterprises Inc (NUS) is a household & personal products company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported NUS revenue for 2024-12-31 was $1.73B. Net income was -$146.6M. Revenue was down 12.0% from 2023-12-31 to 2024-12-31. NUS currently screens at market cap $258.3M and trailing P/E 4.9.
LEN currently screens at market cap $0. NUS currently screens at market cap $258.3M and trailing P/E 4.9.
Not investment advice. Open the LEN and NUS stock pages for the full models.
Not investment advice.